Skip to content
Review Open access

Physical exercise as a therapeutic strategy in animal models of Alzheimer's disease: Molecular, behavioral, and histopathological evidence

Sep 2026 · Biochemistry and Biophysics Reports · Vol 48, pp. 102765 · 0 citations · 50 references
Medicine

TL;DR

Physical exercise has been linked to lower oxidative stress and neuroinflammation, enhanced cognitive function, and fewer pathological changes in animal models of AD, however, variability in disease models and exercise protocols makes it difficult to identify the best exercise approach.

Abstract

Background Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide, imposing a substantial economic burden. As the population ages and cases rise, interest in early identification, prevention, and treatment has intensified. After establishing that pathology involves neurofibrillary tangles, neuroinflammation, and neuronal loss, interventions have been tested in laboratory animals to slow disease progression. One commonly tested intervention is physical exercise, an economical approach. Laboratory animal models of AD aim to demonstrate how different types and intensities of exercise affect disease pathology. This review aims to categorize and elucidate the mechanisms and their outcomes. Materials and methods Original manuscripts concerning the impact of exercise, with or without medicinal intervention, on Alzheimer's dementia progression modeled in laboratory animals from 2020 onwards were included. The routes through which exercise exerts its impact at molecular, behavioral, and histomorphological levels were categorized. Results The most frequent modeling approach was Aβ injection into the hippocampus of Wistar rats, followed by Streptozocin and other chemicals, and transgenic models. Exercise mainly consisted of treadmill or swimming. Interventions were categorized into short-, medium-, and long-term protocols, ranging from 3 to 24 weeks, with most at 4 weeks, 30–60 min per session, 5 days/week. Molecular tests primarily measured Reactive Oxygen Species (ROS), while the most common behavioral test was the Morris Water Maze (MWM), assessing learning and memory. Histopathological assessments focused on β-Amyloid plaque formation, dark cells, and glial activation. Most studies agreed on AD modeling methods, but exercise protocols varied in intensity, duration, and type. The combined use of molecular, behavioral, and histological tests to assess intervention effects was consistent. Conclusion Physical exercise has been linked to lower oxidative stress and neuroinflammation, enhanced cognitive function, and fewer pathological changes in animal models of AD. However, variability in disease models and exercise protocols makes it difficult to identify the best exercise approach.

Read PDF

Similar papers

Review Aug 2026

Autophagy as a mechanistic link between physical exercise and Alzheimer's disease.

Alzheimer's Disease (AD), the most prevalent cause of dementia worldwide, is a neurodegenerative disorder that currently has no cure. A growing body of evidence suggests that physical exercise is a potential non-pharmacological strategy in the treatment of AD. Recent findings highlight the involvement of autophagy in t...

Zhouye Yu, Yan-fang Wang, Yi Yang · 0 citations
Sep 2026

Triptolide preserves cognitive function and reduces hippocampal inflammation in a mouse model of Alzheimer's disease.

Results suggest that T10 improves learning and cognitive performance and reduces hippocampal inflammatory responses in 5xFAD mice, supporting its further investigation as a potential therapeutic intervention for AD.

Xue-Hai Ma, Wei-Ming Li, Yu-Mei Ma et al. · 0 citations
Review Open access Sep 2026

A Comprehensive Review on Alzheimer's Disease and Efficacy of Medicinal Plants’

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease and the primary cause of dementia in the world, responsible for around 60-70% of cases of dementia. Symptoms include progressive cognitive deterioration, memory loss, behavioural changes and inability to independently perform activities of daily l...

P. M. Sagar, N. N · 0 citations
Open access Sep 2026

Resveratrol as a Neuroprotective Bridge from Blue Zone Longevity to Alzheimer's Prevention

Alzheimer's disease is the most common type of dementia among older adults in ageing populations, and the pathological changes that occur before symptoms appear are too extensive; therefore, the focus of research has shifted from late-stage treatment to prevention. This paper investigates whether the low chronic-diseas...

Rui-Tong Liu · 0 citations
Review Open access Sep 2026

Alzheimer’s Disease in the Era of Geroscience: Mechanisms, Biomarkers, and Therapeutic Prospects

Alzheimer’s disease (AD) is the leading cause of dementia and a heterogeneous neurodegenerative disorder characterized by amyloid-β (Aβ) and tau pathology, impaired proteostasis, neurovascular dysfunction, maladaptive glial and immune responses, and synaptic dysfunction. Human genetic evidence supports an upstream role...

P. Chmielewski · 0 citations
Review Open access Sep 2026

The Role of Curcumin in Neurogenesis and Neuroprotection in Alzheimer’s disease: From Molecular Mechanisms to Clinical Evidence

This review discusses multi-target neuroprotective mechanisms of curcumin, critically reviews the preclinical success and human clinical trial outcomes, and highlights advanced nano formulations (solid lipid nanoparticles, colloidal sub-micron dispersions, polymeric nanoparticles, multi-walled carbon nanotubes and exos...

V. S, Sarupruthiya M, Jeevitha D et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.